Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NANOSONICS LIMITED Director's Dealing 2017

Sep 17, 2017

65405_rns_2017-09-17_eb589f9e-bbce-48f1-9301-2539068e89cc.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity Nanosonics Limited ABN 11 095 076 896

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director Mr Michael Kavanagh
Date of last notice 15 September 2017

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest a) Indirect Interest
b) Indirect Interest
c)
Indirect Interest
d) Indirect Interest
e) Direct Interest
Nature of indirect interest
(including registered holder)
Note: Provide details of the circumstances giving rise to the relevant
interest.
a)
Performance
Rights
held
in
the
Nanosonics Employee Share Option
Plan.
b)
Shares held under the Nanosonics
Deferred Employee Share Plan (Trust)
c)
Performance
Rights
held
in
the
Nanosonics Omnibus Equity Plan
d)
Options
held
in
the
Nanosonics
Omnibus Equity Plan
Date of change 18 September 2017
  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change a) 206,882 Performance Rights held in the
Nanosonics Employee Share Option Plan.
b) 1,618,540(Indirect) Ordinary Shares
c) 78,961 Performance Rights held in the
Nanosonics Omnibus Equity Plan.
d) 211,306 Options held in the Nanosonics
Omnibus Equity Plan
e) 150,000 (Direct) Ordinary Shares
Class a) Performance Rights
b) Ordinary Shares
c) Performance Rights
d) Options
e) Ordinary shares
Number acquired 36,823 Ordinary Shares
Number disposed 36,823Performance Rights held under
the Nanosonics Omnibus Equity Plan.
Value/Consideration
Note: If consideration is non-cash, provide details and estimated
valuation
N/A
No. of securities held after change a) 206,882 Performance Rights held in the
Nanosonics Employee Share Option
Plan.
b) 1,655,363(Indirect) Ordinary Shares
c) 42,138 Performance Rights held in the
Nanosonics Omnibus Equity Plan.
d) 211,306 Options held in the Nanosonics
Omnibus Equity Plan
e) 150,000 (Direct) Ordinary Shares
Nature of change
Example: on-market trade, off-market trade, exercise of options,
issue of securities under dividend reinvestment plan, participation in
buy-back
Exercise of 36,823 Performance Rights
under the terms and conditions of the
Nanosonics Omnibus Equity Plan.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
  • See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailed above traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to proceed during this period? If prior written clearance was provided, on what date was this provided?

Director: Mr. Michael Kavanagh Date: 18 September 2017

  • See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3